Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Elandsfontein Update

16 Mar 2020 11:46

RNS Number : 2833G
Kropz PLC
16 March 2020
 

16 March 2020

Kropz Plc("Kropz" or the "Company")

Elandsfontein Update

 

Water Tribunal ("Tribunal")

Kropz plc (AIM: KRPZ), an emerging African phosphate explorer and developer, advises that, further to the announcement on 12 February 2020, the appeal hearing against Elandsfontein's valid integrated water use licence ("WUL") which was due to reconvene today, has been postponed. The postponement has been ordered by the Chairperson of the Tribunal as certain parties undergo routine self-quarantine under government guidelines for persons recently arrived from COVID-19 affected regions. The hearing will therefore be delayed while the Tribunal reviews alternative dates and arrangements. The Company will provide an update when further information is available.

Pending the Tribunal's decision, there is no legal impediment to the continuation of the water use activities authorised in the WUL.

Corporate update

As detailed in the Company's announcement dated 14 February 2020, the Company's subsidiary, Kropz Elandsfontein Pty (Ltd) ("Kropz Elandsfontein"), has a project finance facility with BNP Paribas S.A. ("BNPP") for US$30 million, which is currently fully drawn. As previously announced, due to delays in finalising a comprehensive funding package for the Elandsfontein phosphate mine ("the Project"), the Company advises that Kropz Elandsfontein continues to be in technical default of the BNPP facility. The Company and Kropz Elandsfontein remain in ongoing constructive dialogue with BNPP to remedy the breach and confirm that no capital repayments are due under the current BNPP facility until 30 September 2020.

Further to the Company's announcement dated 26 February 2020, the Company has entered into a ZAR30 million (approximately US$1.83 million) loan facility with its major shareholder, the ARC Fund, of which ZAR5 million (approximately US$305 000) has been drawn down. This facility meets the Company's short-term cash requirements to progress the Project to April 2020, as detailed in the Company's announcement on 14 February 2020, while discussions on the comprehensive funding solution are ongoing.

 

For further information visit www.kropz.com or contact:

 

Kropz Plc

 

Mark Summers (interim-CEO)

+27 (0)79744 8708

 

 

Grant Thornton UK LLP

Nominated Adviser

Richard Tonthat

Samantha Harrison

Niall McDonald

+44 (0) 20 7383 5100

 

 

Hannam & Partners

Joint Broker

Andrew Chubb

Ernest Bell

 +44 (0)20 7907 8500

 

Mirabaud Securities Ltd

Joint Broker

Rory Scott

Edward Haig-Thomas

+44 (0)20 3167 7220

+44 (0)20 3167 7222

 

 

Tavistock

Financial PR & IR (UK)

Emily Moss

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0)11 880 3924

james@rasc.co.za 

 

About Kropz Plc

Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate mining project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDJFMBTMTIBBIM
Date   Source Headline
27th Mar 20247:00 amRNSFurther loan facility
29th Feb 20247:00 amRNSManagement Update
24th Jan 202410:48 amRNSTrading Update
17th Jan 202411:41 amRNSDrawdown on Bridge Loan Facilities
21st Dec 20239:13 amRNSBNP Loan Facility Agreement Update
15th Dec 202311:13 amRNSFurther loan facility, update on BNP Paribas loan
8th Dec 202312:06 pmRNSDrawdown on Equity Facility and Bridge Loan
8th Nov 20232:33 pmRNSChange of Accounting Reference Date
23rd Oct 202311:13 amRNSDrawdown on Bridge Loan Facilities
3rd Oct 202311:04 amRNSBNP loan facility agreement update
28th Sep 202312:47 pmRNSUnaudited Half Year Results
18th Sep 20232:03 pmRNSDrawdown on Bridge Loan Facilities
14th Sep 202311:44 amRNSLoan Facility
1st Sep 20231:40 pmRNSResult of General Meeting
18th Aug 20231:20 pmRNSDrawdown on Bridge Loan Facilities
31st Jul 20237:30 amRNSRestoration - Kropz plc
31st Jul 20237:00 amRNSFinal Audited Results
3rd Jul 20237:30 amRNSSuspension - Kropz plc
30th Jun 20232:24 pmRNSResult of AGM
30th Jun 20237:00 amRNSTrading update, Update on Annual Accounts
23rd Jun 20234:35 pmRNSDrawdown on Bridge Loan Facilities
7th Jun 20234:19 pmRNSNotice of Annual General Meeting
25th Apr 20239:02 amRNSPhosphate project sales update & further drawdown
28th Mar 20238:33 amRNSDrawdown on Bridge Loan Facilities
14th Mar 20237:50 amRNSElandsfontein update and further bridge loan
27th Feb 202310:08 amRNSDrawdown On New Convertible Equity Facility
25th Jan 20233:10 pmRNSDrawdown On New Convertible Equity Facility
23rd Jan 20231:41 pmRNSFirst Bulk Sale From Elandsfontein Project
16th Jan 20232:02 pmRNSAppointment of Chief Executive Officer
10th Jan 20238:44 amRNSUpdate Mineral Resource Estimate - Elandsfontein
22nd Dec 20221:30 pmRNSDrawdown On New Convertible Equity Facility
19th Dec 20227:00 amRNSDirector and Management Changes, and Sales Update
7th Dec 20221:20 pmRNSManagement Changes
1st Dec 202210:43 amRNSDraw down on new convertible equity facility
30th Nov 202212:37 pmRNSResult of General Meeting
21st Nov 20221:45 pmRNSUpdate on New Convertible Facility Agreement
14th Nov 20227:00 amRNSNew Convertible Facility Agreement
28th Oct 20223:20 pmRNSDrawdown on Bridge Loan Facility
24th Oct 20227:00 amRNSElandsfontein update
6th Oct 20227:00 amRNSDrawdown on Bridge Loan Facility
30th Sep 20223:44 pmRNSUnaudited Half Year Results
30th Sep 20222:00 pmRNSElandsfontein bridge loan facility
29th Sep 20223:34 pmRNSDrawdown on Bridge Loan Facility
14th Sep 20227:00 amRNSDirectorate Change
1st Sep 202210:33 amRNSDrawdown on Bridge Loan Facility
9th Aug 20222:05 pmRNSSecond Price Monitoring Extn
9th Aug 20222:00 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSElandsfontein update, drawdown & bridge loan
25th Jul 20222:33 pmRNSResult of General Meeting
20th Jul 20227:00 amRNSNotice of Director Resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.